NCT04366726View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 9, 2019

Primary Completion Date

May 14, 2019

Study Completion Date

May 14, 2019

Conditions

Postmenopausal Osteoporosis

Interventions

COMBINATION_PRODUCT

abaloparatide-sMTS

Abaloparatide-sMTS is a drug-device combination product consisting of the drug abaloparatide coated onto an sMTS array for transdermal administration of abaloparatide.

Trial Locations (1)

66219

Pharmaceutical Research Associates, Inc, Lenexa

All Listed Sponsors

lead

Radius Health, Inc.

INDUSTRY

NCT04366726 - Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD) | Biotech Hunter | Biotech Hunter